Le Lézard
Classified in: Science and technology, Business
Subject: BUSINESS CONTRACTS

Calian Wins $23 Million Contract for New Military Medical Training Program with the Canadian Armed Forces


OTTAWA, April 25, 2024 (GLOBE NEWSWIRE) -- Calian Group Ltd. (TSX: CGY), a provider of diverse and innovative solutions in healthcare, communications, learning and cybersecurity, has been awarded a significant contract by the Canadian Armed Forces' Canadian Forces Health Services Group (CFHSG). Valued at $17 million for three years with an option to extend for a fourth year, potentially increasing the total value to $23 million, this contract highlights Calian's commitment to leveraging its military training and simulation expertise alongside its advanced medical capabilities to offer unparalleled, mission critical support to the CAF.

Calian will deliver comprehensive administrative, instructional and courseware development solutions to enhance CFHSG training initiatives across Canada, including support for the Royal Canadian Dental Corps and Canadian Forces Medical Services. Work will bolster critical training programs at military bases across the country to include environmental medicine development, engineering and evaluation of human performance and protective systems, combat medical simulation, and operational medicine and dental practices. Calian's work will enable an increase in training throughput with the introduction of eLearning, allowing the CAF to more efficiently meet operational readiness goals.

"This contract signifies a milestone achievement, combining Calian's longstanding expertise in both military training and healthcare services to fulfill critical training needs," says Kevin Ford, CEO, Calian. "Our ability to integrate these domains seamlessly has been instrumental in securing this opportunity with the Canadian Armed Forces."

For over 25 years, Calian has been at the forefront of delivering sophisticated military training and simulation solutions to the CAF. The expertise of Calian's training division in developing cutting-edge eLearning and distance learning platforms will complement its health services' capabilities in medical training, resulting in a cohesive, innovative solution that supports the CAF's objectives to elevate operational readiness. This project further illustrates how Calian's health and training divisions collaborate to streamline and enhance training delivery.

"A tailored approach to training is crucial?which means connecting the right expertise with specific needs to ensure high efficacy in all situations," explains Jay Ballard, VP, Defence Learning, Calian. "Our comprehensive understanding of the CAF's operational requirements, paired with our dual capabilities in health and training solutions, enables us to craft customized training solutions that precisely address the needs of each training program."

As a global military training and simulation leader, Calian uses an innovative blend of technology solutions, training and simulation, and the experience and expertise of the entire team to design, develop and deliver training to meet any objective. For more on Calian as the training partner of choice, visit  Calian Defence

About Calian
www.calian.com
We keep the world moving forward. Calian® helps people communicate, innovate, learn and lead safe and healthy lives. Every day, our employees live our values of customer commitment, integrity, innovation, respect and teamwork to engineer reliable solutions that solve complex problems. That's Confidence. Engineered. A stable and growing 40-year company, we are headquartered in Ottawa with offices and projects spanning North American, European and international markets. Visit calian.com to learn about innovative healthcare, communications, learning and cybersecurity solutions.

Product or service names mentioned herein may be the trademarks of their respective owners.

Media inquiries:
[email protected]
613-599-8600 x 2298

Investor Relations inquiries:
[email protected]

-----------------------------------------------------------------------------
DISCLAIMER
Certain information included in this press release is forward-looking and is subject to important risks and uncertainties. The results or events predicted in these statements may differ materially from actual results or events. Such statements are generally accompanied by words such as "intend", "anticipate", "believe", "estimate", "expect" or similar statements. Factors which could cause results or events to differ from current expectations include, among other things: the impact of price competition; scarce number of qualified professionals; the impact of rapid technological and market change; loss of business or credit risk with major customers; technical risks on fixed price projects; general industry and market conditions and growth rates; international growth and global economic conditions, and including currency exchange rate fluctuations; and the impact of consolidations in the business services industry. For additional information with respect to certain of these and other factors, please see the Company's most recent annual report and other reports filed by Calian with the Ontario Securities Commission. Calian disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. No assurance can be given that actual results, performance or achievement expressed in, or implied by, forward-looking statements within this disclosure will occur, or if they do, that any benefits may be derived from them.

Calian · Head Office · 770 Palladium Drive · Ottawa · Ontario · Canada · K2V 1C8
Tel: 613.599.8600 · Fax: 613-592-3664 · General info email: [email protected] 



These press releases may also interest you

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

4 mai 2024
U.S.-based tech startup Iozera, in collaboration with the Government of Morocco, announces an initiative set to transform the AI industry. Iozera has announced the signing of a Memorandum of Understanding (MOU) for the establishment of a pioneering...

4 mai 2024
OKX, a leading Web3 technology company, has issued updates for May 3, 2024. OKX today announced that its Web3 Wallet is now...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

4 mai 2024
With a remarkable achievement of 81.556 billion yuan in operating revenue, marking an 11.74% increase from the previous year, and a net profit attributable to shareholders of 7.039 billion yuan, soaring by 27.21%, JA Solar hit historic highs in both...

4 mai 2024
Leading research and experience management firm Sogolytics will showcase innovations in HR and employee experience at UNLEASH America next week. "With such a rapid evolution in the world of HR tech, we're seeing some major changes in how employers...



News published on and distributed by: